BCHE and neurodegenerative disease: These compounds have emerged as a promising concept to address the multifactorial nature of neurodegenerative diseases, as they can combine MAO activity regulation with complementary actions such as cholinesterase inhibition, adenosine or histamine receptor modulation, and antioxidant effects.